NaifaL.BusaidyMD
Endocrinology • Houston, TXDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Thyroid
Physician
Dr. Busaidy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004- Baylor College of MedicineResidency, Internal Medicine, 1998 - 2001
- Baylor College of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2004 - 2025
WA State Medical License 2022 - 2025
AL State Medical License 2022 - 2024
MS State Medical License 2022 - 2024
GA State Medical License 2022 - 2024
AZ State Medical License 2022 - 2024- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Continuous Glucose Monitoring in Critically Ill Start of enrollment: 2008 Jun 01
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer Start of enrollment: 2012 Nov 07
Publications & Presentations
PubMed
- Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.Bassett, R., Zafereo, M., Hyde, S., Hensley, S., Hu, M., Ying, A., Perrier, N., Busaidy, N., Grubbs, E., Waguespack, S.> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Mar 4
- Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.Anastasios Maniakas, Andrew Sullivan, Mimi I Hu, Naifa L Busaidy, Maria E Cabanillas, Ramona Dadu, Steven G Waguespack, Sarah B Fisher, Paul H Graham, Neil D Gross, El...> ;Head & Neck. 2024 Feb 1
- Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Thomas Szabo Yamashita, Aditya S Shirali, Salyna Meas, Vanessa Sarli, Uriel E Clemente-Gutierrez, Yi-Ju Chiang, Angelica Silva-Figueroa, Danica M Vodopivec, Michelle W...> ;Surgery. 2024 Jan 1
- Join now to see all
Journal Articles
- Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive IodineThinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism
- Selective RET Kinase Inhibition for Patients with RET-Altered CancersL J Wirth, N L Busaidy, M E Cabanillas, Annals of Oncology
Press Mentions
VIDEO: Thyroid ‘Year in Review’ Covers Clinical Studies with ImpactNovember 1st, 2019- New Treatments, New Outcomes for Refractory Thyroid CancerJuly 10th, 2019
The Future of Cancer Diagnosis and Treatment: Liquid Biopsies Can Reveal Cancer and MoreNovember 13th, 2017
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
